Evidence map›Paper›PMID 26036599›Full record

ReviewJournal of endocrinological investigation2015

A review on the effects of Allium sativum (Garlic) in metabolic syndrome.

A Hosseini, H Hosseinzadeh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of endocrinological investigation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Frontiers in nutrition · 2023
    Pooled it
  2. Review
  3. Ashwagandha (Iranian journal of basic medical sciences · 2026
    Review
  4. Article
  5. Article
  6. Protective effects ofToxicology reports · 2025
    Article
  7. Current Findings onPlants (Basel, Switzerland) · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Foods (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Effects ofIranian journal of basic medical sciences · 2022
    Review
  17. Review
  18. A review of the effects ofIranian journal of basic medical sciences · 2022
    Review
  19. Review
  20. The effect ofIranian journal of basic medical sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A HosseiniPharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
H HosseinzadehPharmaceutical Research Center, Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. hosseinzadehh@mums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The metabolic syndrome is a common problem world-wide and includes abdominal obesity, hypertension, dyslipidemia, and hyperglycemia disorders. It leads to insulin resistance and the development of diabetes mellitus or cardiovascular disease. Allium sativum (garlic) has been documented to exhibit anti-diabetic, hypotensive, and hypolipidemic properties. This suggests a potential role of A. sativum in the management of metabolic syndrome; however, more studies should be conducted to evaluate its effectiveness. In this review, we discussed the most relevant articles to find out the role of A. sativum in different components of metabolic syndrome and cardiovascular disease risk factors. Because human reports are rare, further studies are required to establish the clinical value of A. sativum in metabolic syndrome.

Indexed as

GarlicAnimalsAntihypertensive AgentsDisulfidesHumansHypoglycemic AgentsHypolipidemic AgentsMetabolic SyndromeSulfinic AcidsallicinAntihypertensive AgentsDisulfidesHypoglycemic AgentsHypolipidemic AgentsSulfinic AcidsAllium sativumCardiovascular diseaseDiabetesDyslipidemiaGarlicHypertensionMetabolic syndromeObesity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.